LeonaBio (LONA) Other Non Operating Income (2019 - 2026)
LeonaBio (LONA) reported Other Non Operating Income of $586000.0 for Q1 2026, up 49.11% year-over-year from $393000.0 in Q1 2025, and up 129.8% quarter-over-quarter from $255000.0 in Q4 2025.
LeonaBio (LONA) Other Non Operating Income (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Other Non Operating Income data on file, last reported at $586000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $586000.0, up 49.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 52.45% YoY), and the FY2025 annual result was $1.2 million, down 68.8% from the prior year.
- Other Non Operating Income grew to $586000.0 in Q1 2026 per LONA's latest filing, from $255000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $2.1 million in Q3 2023 and troughed at $173000.0 in Q1 2022.
- A 5-year average of $978647.1 and a median of $880000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 1419.42% in 2022, then slumped 72.2% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $1.6 million in 2022, then gained by 10.48% to $1.7 million in 2023, then tumbled by 67.44% to $563000.0 in 2024, then sank by 54.71% to $255000.0 in 2025, then surged by 129.8% to $586000.0 in 2026.
- Business Quant data shows LONA's Other Non Operating Income at $586000.0 in Q1 2026, $255000.0 in Q4 2025, and $263000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 586,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 325,000.00 |
| Mar 31, 2025 | 393,000.00 |
| Dec 31, 2024 | 563,000.00 |
| Sep 30, 2024 | 880,000.00 |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Sep 30, 2022 | 985,000.00 |
| Jun 30, 2022 | 493,000.00 |
| Mar 31, 2022 | 173,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Sep 30, 2021 | 73,000.00 |
| Jun 30, 2021 | 74,000.00 |